Synonyms:Orantinib, TSU-68, 252916-29-3, 210644-62-5, SU-6668, SU6668, SU 6668, TSU 68, Orantinib [INN], (Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid, NSC 702827, Orantinib (SU6668), 2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid, 3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid, NSC-702827, TSU68, CHEMBL274654, TSU-68 (Random Configuration), PDGFR Tyrosine Kinase Inhibitor VI, SU6668, 9RL37ZZ665, 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid, 3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone, 3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid, 3-{2,4-Dimethyl-5-[(Z)-(2-Oxo-1,2-Dihydro-3h-Indol-3-Ylidene)methyl]-1h-Pyrrol-3-Yl}propanoic Acid, Orantinibum, 3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid, 5-((1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid, 1H-Pyrrole-3-propanoic acid, 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, 1H-Pyrrole-3-propanoic acid, 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, Orantinib (TSU-68), 245036-27-5, UNII-9RL37ZZ665, TUS-68, (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid, 1H-Pyrrole-3-propanoic acid, 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, SU006668, Orantinib; SU-6668, ORANTINIB [WHO-DD], 3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid, MLS006011090, SCHEMBL134661, BDBM4811, GTPL7816, EX-A471, BCPP000059, DTXSID101017164, HMS3413J06, HMS3677J06, 1044712-39-1, Orantinib (TSU-68, SU6668), TSU-68 (SU6668, Orantinib), MFCD09743433, NSC702827, NSC763929, NSC800809, s1470, TSU-68 - SU6668, AKOS024457561, CCG-267578, CS-0197, DB12072, NSC-763929, NSC-800809, SU-6597, NCGC00387029-01, AC-25028, AS-16238, BT162331, HY-10517, SMR004702878, Pdgfr tyrosine kinase inhibitor vi,su6668, SW219790-1, EC-000.2125, A879274, J-013813, J-502593, BRD-K55966568-001-01-3, Q27088210, PDGFR Tyrosine Kinase Inhibitor VI, SU6668 - CAS 210644-62-5, 3-[2,4-dimethyl-5-[(Z)-(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid, 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid, (z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1h-pyrrol-3-yl]-propionic acid, 1H-Pyrrole-3-propanoicacid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, 3-(2,4-DIMETHYL-5-(((3Z)-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-1H-PYRROL-3-YL)PROPANOIC ACID, 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid, 5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid
Pubchem:PUBCHEM:5329099
Id:421e3ba5-38e2-5aa8-8f95-3266467f3c67
Description:nan
